BioCentury
ARTICLE | Finance

SVB Leerink’s full suite

Company, banker perspectives on SVB Leerink merger

November 16, 2018 9:46 PM UTC

The planned $280 million acquisition of Leerink Partners by SVB Financial Group (NASDAQ:SIVB) is expected to provide biotechs with a new one stop shop for financial services.

SVB, a commercial lender with a dedicated healthcare team, provided debt financing for nearly two-thirds of VC-backed life science and healthcare companies that went public in the U.S. this year. ...